Xenonics Appeals Notice of Delisting From NYSE Amex

CARLSBAD, Calif.--(BUSINESS WIRE)--XENONICS HOLDINGS, INC. (NYSE AMEX: XNN) announced today that it has received notice from the NYSE Amex (the "Exchange") that the Company failed to regain compliance with continued listing standards and, accordingly, the Company's securities are subject to delisting proceedings. Specifically, Xenonics is not in compliance with Section 1003(a)(iii) of the Company Guide because it has shareholders' equity of less than $6,000,000.

In accordance with Sections 1203 and 1009(d) of the Company Guide, Xenonics has the right to appeal the Staff Determination by requesting a hearing before a Listing Qualifications Panel. The Company plans to exercise this right, and expects the hearing to occur within the next 45 to 60 days. In the meantime, the Company's securities will continue to be listed on the NYSE Amex.

About Xenonics

Xenonics Holdings, Inc. (NYSE AMEX: XNN) develops and produces advanced, lightweight and compact ultra-high-intensity illumination and low-light vision products for military, law enforcement, public safety, and commercial and private sector applications. Xenonics' NightHunter line of illumination products is used by every branch of the U.S. Armed Forces as well as law enforcement and security agencies. Its SuperVision high-definition night vision is designed for commercial and military applications. Employing patented technologies, Xenonics provides innovative solutions for customers who must see farther so they can do their jobs better and safer. Xenonics' products represent the next generation in small, high intensity, high efficiency illumination and low-light vision systems. Visit Xenonics on the web at www.xenonics.com.

Forward-Looking Statements

Except for the historical statements, statements in this release may constitute forward-looking statements within the meaning of section 21E of the Securities Exchange Act of 1934. When used, the words "anticipates," "believes," "expects," "intends," "future," and other similar expressions identify forward-looking statements. These forward-looking statements reflect management's current views with respect to future events and financial performance and are subject to risks and uncertainties, and actual results may differ materially from the outcomes contained in any forward-looking statement. Factors that could cause these forward-looking statements to differ from actual results include delays in development, marketing or sales of new products, and other risks and uncertainties discussed in the company's periodic reports on Form 10-K and 10-Q and other filings with the Securities and Exchange Commission. Xenonics Holdings undertakes no obligation to update or revise any forward-looking statements.